Accelerating drug discovery by using AI to make better decisions early, leading to faster, cheaper, and more reliable drug development.

Peptris uses an AI-powered platform to computationally optimize and prioritize novel and repurposed drug candidates. This is done by predicting molecular interactions, safety, and various properties before wet-lab testing. By focusing on making higher-quality decisions at the earliest stages of discovery - the platform cuts development timelines and costs while improving success rates across rare diseases, oncology, and inflammation, enabling faster translation of promising science into viable therapies.